Not controlling diet AOD 9604 enhances fat burning
The ratio of beta to alpha-2 receptors determines how readily a fat depot releases stored energy
Product Attributes CAS # : 1034043-18-3 Molecular Formula : C10H11N2+ (free base), C10H11IN2 (iodide salt), C10H11ClN2 (chloride salt) Sequence (AA) : N/A (small molecule) Molecular Weight : 215.26 g/mol PubChem CID : 950107 (free base), 66522933 (iodide salt) Half-Life : 3.8-6.9 hours Synonyms : 5-Amino-1-methylquinolinium-1-ium, NNMT Inhibitor 5A1MQ, NNMTi, Amino-1MQ, 1-MQ, Type : Synthetic small molecule analog Research Focus : Weight Loss, Mitochondrial Function, Longevity, Metabolic Health Scientific References Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice Animal Roles of nicotinamide N-methyltransferase in obesity and type 2 diabetes mellitus Review What is 5-Amino-1MQ
Paradigm Biopharmaceuticals (cartilage): An Australian company, Paradigm Biopharmaceuticals, has advanced AOD-9604 into clinical trials for knee osteoarthritis as an intra-articular injection, representing a significant pivot from weight management to joint health
Safety advantage: Unlike HGH, AOD-9604 does not significantly impact IGF-1, insulin sensitivity, or blood sugar regulation Therapeutic potential: Initially investigated as an anti-obesity drug, it has since gained attention in the wellness and peptide therapy communities for weight loss and metabolic health
What It Is AOD-9604 is a synthetic 16-amino acid fragment derived from the C-terminal region of human growth hormone, specifically residues 176-191
